10182-48-6 | 3,4-Dihydroxypyridine

Packsize	Purity	Availability	Price	Discounted Price
100mg	98%	in stock	$22.00	$16.00
250mg	98%	in stock	$40.00	$28.00
1g	98%	in stock	$115.00	$81.00
5g	98%	in stock	$495.00	$347.00

Description

• Catalog Number: AA07112
• Chemical Name: 3,4-Dihydroxypyridine
• CAS Number: 10182-48-6
• Molecular Formula: C5H5NO2
• Molecular Weight: 111.0987
• MDL Number: MFCD01691806
• SMILES: Oc1cnccc1O

Computed Properties

• Complexity: 169
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 8
• Hydrogen Bond Acceptor Count: 3
• Hydrogen Bond Donor Count: 2

Upstream Synthesis Route

The versatile compound 3,4-Dihydroxypyridine is prominently utilized in chemical synthesis as a crucial building block in various organic reactions. Its unique structure and reactivity make it an essential component in the preparation of complex molecules and pharmaceutical intermediates. In chemical synthesis, 3,4-Dihydroxypyridine serves as a key intermediate for the synthesis of biologically active compounds, including drugs and agrochemicals. Its ability to undergo selective functionalization reactions enables chemists to introduce specific functional groups at precise positions on the pyridine ring, facilitating the synthesis of diverse molecular structures.Furthermore, 3,4-Dihydroxypyridine plays a pivotal role in the construction of heterocyclic scaffolds, which are prevalent in pharmaceuticals and natural products. By incorporating this compound into synthetic pathways, chemists can access a wide range of heterocyclic derivatives with varied pharmacological activities.Overall, the strategic use of 3,4-Dihydroxypyridine in chemical synthesis demonstrates its significance as a valuable tool for accessing complex molecular architectures and advancing the development of innovative compounds in the fields of medicine and agrochemicals.

Literature

• Characterization of the aqueous iron(III) chelation chemistry of a potential Trojan Horse antimicrobial agent: chelate structure, stability and pH dependent speciation.

  Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine 20121001

• Prediction of 3-hydroxypyridin-4-one (HPO) log K1 values for Fe(III).

  Dalton transactions (Cambridge, England : 2003) 20120921

• Prediction of 3-hydroxypyridin-4-one (HPO) hydroxyl pKa values.

  Dalton transactions (Cambridge, England : 2003) 20120607

• Design and synthesis of fluorinated iron chelators for metabolic study and brain uptake.

  Journal of medicinal chemistry 20120308

• Computer-aided design of novel antibacterial 3-hydroxypyridine-4-ones: application of QSAR methods based on the MOLMAP approach.

  Journal of computer-aided molecular design 20120301

• Investigation of the insulin-like properties of zinc(II) complexes of 3-hydroxy-4-pyridinones: identification of a compound with glucose lowering effect in STZ-induced type I diabetic animals.

  Journal of inorganic biochemistry 20111201

• Synthesis, iron(III)-binding affinity and in vitro evaluation of 3-hydroxypyridin-4-one hexadentate ligands as potential antimicrobial agents.

  Bioorganic & medicinal chemistry letters 20111101

• Design of clinically useful macromolecular iron chelators.

  The Journal of pharmacy and pharmacology 20110701

• Synthesis and intestinal transport of the iron chelator maltosine in free and dipeptide form.

  European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20110501

• New hydroxypyridinone-functionalized sepharoses as sorbing agents for hard metal ions.

  Journal of hazardous materials 20110227

• In vitro inhibition of bacterial growth by iron chelators.

  FEMS microbiology letters 20110101

• A gallium complex with a new tripodal tris-hydroxypyridinone for potential nuclear diagnostic imaging: solution and in vivo studies of 67Ga-labeled species.

  Journal of inorganic biochemistry 20110101

• Adaptation of Rhizobium leguminosarum to pea, alfalfa and sugar beet rhizospheres investigated by comparative transcriptomics.

  Genome biology 20110101

• Application of different chemometric tools in QSAR study of azolo-adamantanes against influenza A virus.

  Research in pharmaceutical sciences 20110101

• Synthesis and biological evaluation of bidentate 3-hydroxypyridin-4-ones iron chelating agents.

  Research in pharmaceutical sciences 20110101

• Glucosylated deferiprone and its brain uptake: implications for developing glucosylated hydroxypyridinone analogues intended to cross the blood-brain barrier.

  Journal of medicinal chemistry 20100812

• Fluorescent 3-hydroxy-4-pyridinone hexadentate iron chelators: intracellular distribution and the relevance to antimycobacterial properties.

  Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry 20100801

• Identification of a new hexadentate iron chelator capable of restricting the intramacrophagic growth of Mycobacterium avium.

  Microbes and infection 20100401

• In vitro studies of 3-hydroxy-4-pyridinones and their glycosylated derivatives as potential agents for Alzheimer's disease.

  Dalton transactions (Cambridge, England : 2003) 20100214

• Preparation of pyridine-3,4-diols, their crystal packing and their use as precursors for palladium-catalyzed cross-coupling reactions.

  Beilstein journal of organic chemistry 20100101

• The selective quantification of iron by hexadentate fluorescent probes.

  Bioorganic & medicinal chemistry 20091201

• Combined chelation based on glycosyl-mono- and bis-hydroxypyridinones for aluminium mobilization: solution and biodistribution studies.

  Journal of inorganic biochemistry 20091101

• Classification of 5-HT(1A) receptor ligands on the basis of their binding affinities by using PSO-Adaboost-SVM.

  International journal of molecular sciences 20090801

• Monitoring intracellular labile iron pools: A novel fluorescent iron(III) sensor as a potential non-invasive diagnosis tool.

  Journal of pharmaceutical sciences 20090601

• Synthesis, antimicrobial evaluation and QSAR study of some 3-hydroxypyridine-4-one and 3-hydroxypyran-4-one derivatives.

  European journal of medicinal chemistry 20090501

• New tripodal hydroxypyridinone based chelating agents for Fe(III), Al(III) and Ga(III): Synthesis, physico-chemical properties and bioevaluation.

  Journal of inorganic biochemistry 20090201

• Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.

  BMC medical genomics 20090101

• Synthesis of 4-pyridone-3-sulfate and an improved synthesis of 3-hydroxy-4-pyridone.

  Chemistry Central journal 20090101

• Iron chelation as a potential therapy for neurodegenerative disease.

  Biochemical Society transactions 20081201

• QSAR study of antimicrobial 3-hydroxypyridine-4-one and 3-hydroxypyran-4-one derivatives using different chemometric tools.

  International journal of molecular sciences 20081201

• Pyruvate carboxylase is involved in metabolism of mimosine by Rhizobium sp. strain TAL1145.

  Archives of microbiology 20081001

• Targeting the lysosome: fluorescent iron(III) chelators to selectively monitor endosomal/lysosomal labile iron pools.

  Journal of medicinal chemistry 20080814

• Neuroprotective actions of deferiprone in cultured cortical neurones and SHSY-5Y cells.

  Journal of neurochemistry 20080601

• Gut microbiology - broad genetic diversity, yet specific metabolic niches.

  Animal : an international journal of animal bioscience 20080501

• A new approach for potential combined chelation therapy using mono- and bis-hydroxypyridinones.

  Hemoglobin 20080101

• 55Cobalt complexes with pendant carbohydrates as potential PET imaging agents.

  Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 20071201

• The pydA-pydB fusion gene produces an active dioxygenase-hydrolase that degrades 3-hydroxy-4-pyridone, an intermediate of mimosine metabolism.

  Applied microbiology and biotechnology 20070601

• Multicomponent assembly of boron-based dendritic nanostructures.

  The Journal of organic chemistry 20070316

• Determination of the labile iron pool of human lymphocytes using the fluorescent probe, CP655.

  Analytical chemistry insights 20070101

• Spectroscopic and potentiometric characterization of oxovanadium(IV) complexes formed by 3-hydroxy-4-pyridinones. Rationalization of the influence of basicity and electronic structure of the ligand on the properties of V(IV)O species in aqueous solution.

  Inorganic chemistry 20061002

• Selective determination of mimosine and its dihydroxypyridinyl derivative in plant systems.

  Amino acids 20061001

• Chelation and determination of labile iron in primary hepatocytes by pyridinone fluorescent probes.

  The Biochemical journal 20060401

• New lipophilic 3-hydroxy-4-pyridinonate iron(III) complexes: synthesis and EXAFS structural characterisation.

  Dalton transactions (Cambridge, England : 2003) 20060314

• Synthesis and antiviral evaluation of cyclic and acyclic 2-methyl-3-hydroxy-4-pyridinone nucleoside derivatives.

  Journal of medicinal chemistry 20060112

• Carbohydrate-appended 3-hydroxy-4-pyridinone complexes of the [M(CO)3]+ core (M = Re, 99mTc, 186Re).

  Bioconjugate chemistry 20060101

• High affinity iron(III) scavenging by a novel hexadentate 3-hydroxypyridin-4-one-based dendrimer: synthesis and characterization.

  Bioorganic & medicinal chemistry letters 20051115

• Bifunctional 3-hydroxy-4-pyridinone derivatives as potential pharmaceuticals: synthesis, complexation with Fe(III), Al(III) and Ga(III) and in vivo evaluation with 67Ga.

  Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry 20050801

• N-Arylamine derivatives of 3-hydroxy-4-pyridinones: solution studies and bioevaluation in view of Al-detoxification roles.

  Analytical and bioanalytical chemistry 20050101

• Carbohydrate-bearing 3-hydroxy-4-pyridinonato complexes of gallium(III) and indium(III).

  Bioconjugate chemistry 20050101

• Design, synthesis and properties of novel iron(III)-specific fluorescent probes.

  The Journal of pharmacy and pharmacology 20040401

• Alkylaryl-amino derivatives of 3-hydroxy-4-pyridinones as aluminium chelating agents with potential clinical application.

  Journal of inorganic biochemistry 20030915

• The mid genes of Rhizobium sp strain TAL1145 are required for degradation of mimosine into 3-hydroxy-4-pyridone and are inducible by mimosine.

  Microbiology (Reading, England) 20030201

• Human immunodeficiency virus type 1 replication inhibition by the bidentate iron chelators CP502 and CP511 is caused by proliferation inhibition and the onset of apoptosis.

  European journal of clinical investigation 20020301

• Synthesis and physicochemical assessment of novel 2-substituted 3-hydroxypyridin-4-ones, novel iron chelators.

  The Journal of pharmacy and pharmacology 20020301

• Structure-function investigation of the interaction of 1- and 2-substituted 3-hydroxypyridin-4-ones with 5-lipoxygenase and ribonucleotide reductase.

  The Journal of biological chemistry 20011228

• Cellular zinc content is a major determinant of iron chelator-induced apoptosis of thymocytes.

  Blood 20011215

• Selection of several classes of mimosine-degradation-defective Tn3Hogus-insertion mutants of Rhizobium sp. strain TAL1145 on the basis of mimosine-inducible GUS activity.

  Canadian journal of microbiology 20010601

• Structure-activity investigation of the inhibition of 3-hydroxypyridin-4-ones on mammalian tyrosine hydroxylase.

  Biochemical pharmacology 20010201

• Microbial metabolism of the pyridine ring. The hydroxylation of 4-hydroxypyridine to pyridine-3,4-diol (3,4-dihydroxypyridine) by 4-hydroxypyridine-3-hydroxylase.

  The Biochemical journal 19740501

• Microbial metabolism of the pyridine ring. The metabolism of pyridine-3,4-diol (3,4-dihydroxypyridine) by Agrobacterium sp.

  The Biochemical journal 19740501